European Biosimilars Market Outlook

European Biosimilars Market Outlook

 

RELEASE DATE
24-Sep-2008
REGION
Europe
Research Code: M238-01-00-00-00
SKU: HC01717-EU-MR_06425
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01717-EU-MR_06425

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing market participants. In addition, it includes a segment-wise and country-wise market opportunity analysis followed by recommendations to market participants.

Table of Contents

Glossary of Terms

  • Abbreviations

Research Methodology

  • Research Methodology

Introduction

Market Engineering Research

  • Definition
  • Role of Biosimilars in the European Union
  • Evolution of the Regulatory Pathway in the EU
  • Key Issues Surrounding Biosimilars in the European Union
  • Scope and Segmentation
  • Market Overview

Key European Players

Key Indian Players

Erythropoeitins

Granulocyte Colony Stimulating Factors

Human Growth Hormones

Insulin and Analogs

  • Market Overview

Interferons

  • Market Overview
This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing market participants. In addition, it includes a segment-wise and country-wise market opportunity analysis followed by recommendations to market participants.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number M238-01-00-00-00
Is Prebook No